Principal Investigator
Kamil Detyniecki
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231076
Clinical Trial Summary
A Phase 2/3 Multicenter, Randomized, Double-Blind,
Placebo-Controlled, Study to Evaluate the Efficacy,
Safety and Tolerability of BHV-7000 in Subjects with
Refractory Focal Onset Epilepsy
Phase
Phase II/III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Klenisson Brenner
Phone Number
+1 (305) 2431322
Email
kxb1280@miami.edu